Literature DB >> 26549948

Management of diabetic foot: Brief synopsis for busy orthopedist.

Tae Hwan Park1, Ashish Anand2.   

Abstract

According to available medical reports, over 10% of diabetic patients will develop foot ulcers during their lifetimes. This condition still remains great challenges to many clinicians. Various mechanisms may explain treatment-resistant entity. Treatment varies widely, relying on the severity of the ulceration as well as the presence of infection or ischemia. However, the most important things to keep in mind should consist of the following: 1) appropriate debridement; 2) off-loading of pressure; 3) effective control of infection; 4) local wound care strategy; 5) timely reconstructive surgery. The ideal flap for diabetic foot reconstruction should provide a well-vascularized tissue to control infection, adequate contour for footwear, durability, and solid anchorage to resist shearing forces. A thorough assessment of patient's general condition and voluntary motivation of the patient should be warranted to prevent any sort of postoperative recurrence.

Entities:  

Keywords:  Diabetic; Flap; Reconstruction; Wound

Year:  2014        PMID: 26549948      PMCID: PMC4551462          DOI: 10.1016/j.jcot.2014.10.003

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  66 in total

1.  Debridement of necrotic eschar with 40% urea paste speeds healing of residual limbs and avoids further surgery.

Authors:  M T Pelle; O F Miller
Journal:  Arch Dermatol       Date:  2001-10

Review 2.  Negative pressure wound therapy in treatment of diabetic foot wounds: a marriage of modalities.

Authors:  David G Armstrong; Andrew J M Boulton; Paul Banwell
Journal:  Ostomy Wound Manage       Date:  2004-04       Impact factor: 2.629

3.  Recombinant human platelet-derived growth factor enhanced dermal wound healing by a pathway involving ERK and c-fos in diabetic rats.

Authors:  Biao Cheng; Hong-Wei Liu; Xiao-Bing Fu; Tong-Zhu Sun; Zhi-Yong Sheng
Journal:  J Dermatol Sci       Date:  2007-01-31       Impact factor: 4.563

Review 4.  Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers.

Authors:  David L Steed
Journal:  Plast Reconstr Surg       Date:  2006-06       Impact factor: 4.730

5.  Negative pressure therapy in diabetic foot wounds.

Authors:  Ernst Chantelau
Journal:  Lancet       Date:  2006-03-04       Impact factor: 79.321

6.  The reduction and redistribution of plantar pressures using foot orthoses in diabetic patients.

Authors:  H Kato; T Takada; T Kawamura; N Hotta; S Torii
Journal:  Diabetes Res Clin Pract       Date:  1996-03       Impact factor: 5.602

7.  Evaluation of chronic wound treatment with the SNaP wound care system versus modern dressing protocols.

Authors:  Bruce Lerman; Leslie Oldenbrook; Shaundra L Eichstadt; Justin Ryu; Kenton D Fong; Peter J Schubart
Journal:  Plast Reconstr Surg       Date:  2010-10       Impact factor: 4.730

8.  Lentiviral gene therapy with platelet-derived growth factor B sustains accelerated healing of diabetic wounds over time.

Authors:  Li-Xing Man; Juliet C Park; Michael J Terry; James M Mason; Whitney A Burrell; Fangjun Liu; Brent Y Kimball; Sameer M Moorji; James A Lee; Arnold S Breitbart
Journal:  Ann Plast Surg       Date:  2005-07       Impact factor: 1.539

9.  Apligraf in the treatment of neuropathic diabetic foot ulcers.

Authors:  Michael Edmonds
Journal:  Int J Low Extrem Wounds       Date:  2009-02-03       Impact factor: 2.057

10.  Angiographic evaluation of the anatomic pattern of arterial obstructions in diabetic patients with critical limb ischaemia.

Authors:  A Ciavarella; A Silletti; A Mustacchio; M Gargiulo; M C Galaverni; A Stella; P Vannini
Journal:  Diabete Metab       Date:  1993 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.